{
    "2021-04-02": [
        [
            {
                "time": "2021-03-01",
                "original_text": "Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Top Dividend Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "7 Robinhood Stocks Even Billionaires Want in Their Portfolios",
                "features": {
                    "keywords": [
                        "Robinhood Stocks",
                        "Billionaires",
                        "Portfolios"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Emergent says experimental COVID-19 treatment failed in Phase 3 trial",
                "features": {
                    "keywords": [
                        "Emergent",
                        "COVID-19",
                        "Phase 3 trial",
                        "failed"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Vaccine Stocks Checkup: U.S. Administers Record Doses Thursday",
                "features": {
                    "keywords": [
                        "Vaccine Stocks",
                        "U.S.",
                        "Record Doses"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "U.S. May Not Need AstraZeneca Vaccine, Fauci Tells Reuters",
                "features": {
                    "keywords": [
                        "U.S.",
                        "AstraZeneca",
                        "Fauci",
                        "Reuters"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "When Will Johnson & Johnson Start to Profit From Its COVID Vaccine?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Profit",
                        "COVID Vaccine"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Vaccine Stocks Checkup: 15 Million Johnson & Johnson Doses Ruined",
                "features": {
                    "keywords": [
                        "Vaccine Stocks",
                        "Johnson & Johnson",
                        "Doses Ruined"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}